|
|
 |
|
Viewing report
|
|
|
Aastrom Biosciences Inc (09-Mar-2011)
Directors Deals Ltd, March 2011, Pages: 1
Scott Durbin, (PDMR) Chief Financial Officer of Aastrom Biosciences Inc [market cap £42million] bought 13,537 shares at 2.170USD, holding is now 30,000 shares; representing 0.106 percent of the shares on issue. Holding has increased 82 percent, the total trade value was £18,023 and the significance rating is 65/100.
Directors Deals monitors and analyses share transactions made by directors in the shares of their own company. We monitor 18,000 companies share transactions in 46 countries worldwide (32 in Europe, 7 in Asia, 2 in North America, 2 in Oceania, 2 in the Middle East & 2 in Africa).
|
|
|
|
